Ashok Health Report
Ashok Health Report
Ashok Health Report
Health Summary
BLOOD COUNTS
THYROID PROFILE
Test Name Result
Please Watchout
LIPID PROFILE
DIABETES MONITORING
KIDNEY PROFILE
LIVER PROFILE
ANEMIA STUDIES
ELECTROLYTES
Test Name Result
Everything looks good RDW-SD 49.6
RDW-CV 15.6
Please Watchout
VITAMIN PROFILE
Please Watchout
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Whole blood EDTA Report Date : Mar 24, 2024, 02:39 PM
Barcode No : HY339739 Report Status : Final Report
HEMATOLOGY REPORT
Annual Health Checkup- Advance with Free HsCRP
Complete Blood Count (CBC)
RBC Parameters
Hemoglobin 13 g/dL 13.0 - 17.0
Method : colorimetric
RBC Count 4.8 10^6/µl 4.5 - 5.5
Method : Electrical impedance
PCV 41 % 40 - 50
Method : Calculated
MCV 85.9 fl 83 - 101
Method : Calculated
MCH 27.3 pg 27 - 32
Method : Calculated
MCHC 31.8 g/dL 31.5 - 34.5
Method : Calculated
RDW (CV) * 15.6 % 11.6 - 14.0
Method : Calculated
RDW-SD * 49.6 fl 35.1 - 43.9
Method : Calculated
WBC Parameters
TLC 9.9 10^3/µl 4 - 10
Method : Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 71 % 40-80
Lymphocytes 24 % 20-40
Monocytes 3 % 2-10
Eosinophils 2 % 1-6
Basophils 0 % <2
Absolute Leukocyte Counts
Neutrophils. 7.03 10^3/µl 2-7
Lymphocytes. 2.38 10^3/µl 1-3
Monocytes. 0.3 10^3/µl 0.2 - 1.0
Eosinophils. 0.2 10^3/µl 0.02 - 0.5
Basophils. 0 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 190 10^3/µl 150 - 410
Method : Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 13.5 fL 9.3 - 12.1
Method : Calculated
PCT * 0.3 % 0.17 - 0.32
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 1 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Whole blood EDTA Report Date : Mar 24, 2024, 02:39 PM
Barcode No : HY339739 Report Status : Final Report
Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 2 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Whole blood EDTA Report Date : Mar 24, 2024, 03:02 PM
Barcode No : HY339739 Report Status : Final Report
HEMATOLOGY REPORT
Annual Health Checkup- Advance with Free HsCRP
Erythrocyte Sedimentation Rate (ESR)
ESR - Erythrocyte Sedimentation Rate 32 mm/hr 0 - 10
Method : MODIFIED WESTERGREN
Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 3 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Whole blood EDTA Report Date : Mar 24, 2024, 02:39 PM
Barcode No : HY339739 Report Status : Final Report
HEMATOLOGY REPORT
Annual Health Checkup- Advance with Free HsCRP
HbA1C (Glycosylated Haemoglobin)
Glycosylated Hemoglobin (HbA1c) 10.1 % < 5.7
Method : HPLC
Estimated Average Glucose * 243.17
Interpretation:
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0
Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5
Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still
have a high concentration of HbA1c. Converse is true for a diabetic previously under good control but now poorly controlled.
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant cardiovascular
disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 %
may not be appropriate.
Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as
compared to blood and urinary glucose determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels.
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
10 240 16 413
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 4 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : FLUORIDE F Report Date : Mar 24, 2024, 02:40 PM
Barcode No : ZC091786 Report Status : Final Report
BIOCHEMISTRY REPORT
Annual Health Checkup- Advance with Free HsCRP
Glucose Fasting (BSF)
Glucose Fasting 104.9 mg/dL < 100 mg/dL: Normal
Method : Hexokinase 100–125 mg/dL:
Prediabetes
>=126 mg/dL: Diabetes
Interpretation:
Status Fasting plasma glucose in mg/dL
Normal <100
Impaired fasting glucose 100 - 125
Diabetes =>126
Comment :
Blood glucose determinations in commonly used as an aid in the diagnosis and treatment of diabetes. Elevated glucose levels
(hyperglycemia) may also occur with pancreatic neoplasm, hyperthyroidism, and adrenal cortical hyper function as well as other disorders.
Decreased glucose levels (hypoglycemia) may result from excessive insulin therapy insulinoma, or various liver diseases.
Note
1.The diagnosis of Diabetes requires a fasting plasma glucose of > or = 126 mg/dL or a random / 2 hour plasma glucose value of > or = 200
mg/dL with symptoms of diabetes mellitus.
2.Very high glucose levels (>450 mg/dL in adults) may result in Diabetic Ketoacidosis.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 5 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Serum Report Date : Mar 24, 2024, 02:40 PM
Barcode No : ZC091787 Report Status : Final Report
BIOCHEMISTRY REPORT
Annual Health Checkup- Advance with Free HsCRP
Liver Function Test (LFT)
Bilirubin Total 0.5 mg/dL 0 - 1.2
Method : Colorimetric Diazo
Bilirubin Direct * 0.2 mg/dL 0 - 0.5
Bilirubin Indirect * 0.3 mg/dL 0.1 - 1.0
Method : Calculation (T Bil - D Bil)
SGOT/AST 27.9 U/L up to 40
Method : IFCC without P5P
SGPT/ALT 27 U/L up to 41
Method : IFCC without P5P
SGOT/SGPT Ratio * 1.03 - -
Alkaline Phosphatase 159 U/L 40 - 129
Method : IFCC
Total Protein 7.1 g/dL 6.0 - 7.8
Method : Biuret
Albumin 4.1 g/dL 3.5 - 5.2
Method : Colorimetric
Globulin * 3 g/dL 2.3 - 3.5
Method : Calculation (T.P - Albumin)
Albumin :Globulin Ratio * 1.37 - 1.0 - 2.1
Method : Calculation (Albumin/Globulin)
Gamma Glutamyl Transferase (GGT) * 60 U/L 5 -40
Method : ENZYMATIC
Interpretation:
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood clotting proteins, and
performs many other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical reactions. When liver cells are damaged or
destroyed, the enzymes in the cells leak out into the blood, where they can be measured by blood tests Liver tests check the blood for two main liver enzymes.
Aspartate aminotransferase (AST),SGOT: The AST enzyme is also found in muscles and many other tissues besides the liver. Alanine aminotransferase (ALT),
SGPT: ALT is almost exclusively found in the liver. If ALT and AST are found together in elevated amounts in the blood, liver damage is most likely present.
Alkaline Phosphatase and GGT: Another of the liver's key functions is the production of bile, which helps digest fat. Bile flows through the liver in a system of
small tubes (ducts), and is eventually stored in the gallbladder, under the liver. When bile flow is slow or blocked, blood levels of certain liver enzymes rise:
Alkaline phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in the blood. Alkaline phosphatase is by far
the most commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present. Bile flow problems can be
due to a problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks of all cells and tissues. Proteins are necessary for
your body's growth, development, and health. Blood contains two classes of protein, albumin and globulin. Albumin proteins keep fluid from leaking out of blood
vessels. Globulin proteins play an important role in your immune system. Low total protein may indicate: 1.bleeding 2.liver disorder 3.malnutrition
4.agammaglobulinemia High Protein levels 'Hyperproteinemia: May be seen in dehydration due to inadequate water intake or to excessive water loss (eg, severe
vomiting, diarrhea, Addison's disease and diabetic acidosis) or as a result of increased production of proteins Low albumin levels may be caused by: 1.A poor diet
(malnutrition). 2.Kidney disease. 3.Liver disease. High albumin levels may be caused by: Severe dehydration.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 6 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Serum Report Date : Mar 24, 2024, 02:40 PM
Barcode No : ZC091787 Report Status : Final Report
BIOCHEMISTRY REPORT
Annual Health Checkup- Advance with Free HsCRP
Kidney Function Test (KFT)
Blood Urea 17.9 mg/dL 16.6 - 48.5
Method : Urease
Creatinine 0.8 mg/dL 0.70 - 1.20
Method : Jaffe
Bun * 8.36 mg/dL 6 - 20
Method : Urease
Bun/Creatinine Ratio * 10.45
Urea / Creatinine Ratio * 22.37
Uric Acid 7.8 mg/dL 3.4 - 7.0
Method : Enzymatic colorimetric
Calcium Serum 8.6 mg/dL 8.6 - 10.0
Method : BAPTA
Phosphorus 2.7 mg/dL 2.5 - 4.5
Method : Molybdate UV
Sodium 142 mmol/L 136 - 145
Method : ISE-Indirect
Potassium 4.5 mmol/L 3.5 - 5.1
Method : ISE-Indirect
Chloride 105.1 mmol/L 98 - 107
Method : ISE-Indirect
Interpretation:
Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning. Many
conditions can affect the ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual
(chronic) declineinfunction. Both result in a buildup of toxic waste subst done on urine samples, as well as on blood samples. A number of symptoms may
indicate a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to urinate,difficulty beginning urination,painful
urination,swelling in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring
simultaneously, these symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes
(sodium,potassium,and chloride) are present in the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells
and organs. There has to be a balance.Ionized calcium this test if you have signs of kidney or parathyroid disease. The test may also be done to monitor progress
and treatment of these diseases.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 7 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Serum Report Date : Mar 24, 2024, 02:40 PM
Barcode No : ZC091787 Report Status : Final Report
BIOCHEMISTRY REPORT
Annual Health Checkup- Advance with Free HsCRP
Lipid Profile
Total Cholesterol 179.2 mg/dL <200
Method : Enzymatic - Cholesterol Oxidase
Triglycerides 103.7 mg/dL <150
Method : Colorimetric - Lip/Glycerol Kinase
HDL Cholesterol 44.4 mg/dL >55
Method : Enzymatic colorimetric
Non HDL Cholesterol * 134.8 mg/dL <130
Method : Calculated
LDL Cholesterol * 114.06 mg/dL <100
Method : Calculated
V.L.D.L Cholesterol * 20.74 mg/dL < 30
Method : Calculated
Chol/HDL Ratio * 4.04 Ratio 3.5 - 5.0
Method : Calculated
HDL/ LDL Ratio * 0.39 Ratio 0.5 - 3.0
Method : Calculated
LDL/HDL Ratio * 2.57 Ratio -
Method : Calculated
Interpretation:
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation. NCEP recommends of 3
different samples to be drawn at intervals of 1 week for harmonizing biological variables that might be encountered in single assays.
National Lipid Association Recommendations Total Cholesterol Triglyceride LDL Cholesterol Non HDL Cholesterol
(NLA-2014) (mg/dL) (mg/dL) (mg/dL) (mg/dL)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220
HDL Cholesterol
Low High
<40 >=60
Risk Stratification for ASCVD (Atherosclerotic Cardiovascular Disease) by Lipid Association of India.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 8 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Serum Report Date : Mar 24, 2024, 02:40 PM
Barcode No : ZC091787 Report Status : Final Report
Newer treatment goals and statin initiation thresholds based on the risk categories proposed by Lipid Association of India
in 2020.
References : Management of Dyslipidaemia for the Prevention of Stroke : Clinical practice Recommendations from the Lipid Association of
India. Current Vascular Pharmacology,2022,20,134-155.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 9 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Serum Report Date : Mar 24, 2024, 02:40 PM
Barcode No : ZC091787 Report Status : Final Report
BIOCHEMISTRY REPORT
Annual Health Checkup- Advance with Free HsCRP
High Sensitivity C-Reactive Protein (Hs-CRP)
HIGHLY SENSITIVE C-REACTIVE PROTEIN (hs- 15.8 mg/L Low < 1.00 mg/L
CRP)
Method : Particle enhanced immunoturbidimetric assay. Average 1.0-3.0 mg/L
Comments
High sensitivity C Reactive Protein (hsCRP) significantly improves cardiovascular risk assessment as it is a strongest predictor of future
coronary events. It reveals the risk of future Myocardial infarction and Stroke among healthy men and women, independent of traditional risk
factors. It identifies patients at risk of first Myocardial infarction even with low to moderate lipid levels. The risk of recurrent cardiovascular events
also correlates well with hsCRP levels. It is a powerful independent risk determinant in the prediction of incident Diabetes.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 10 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Serum Report Date : Mar 24, 2024, 04:06 PM
Barcode No : ZC091787 Report Status : Final Report
BIOCHEMISTRY REPORT
Annual Health Checkup- Advance with Free HsCRP
Vitamin B12 / Cyanocobalamin
Vitamin - B12 110.7 pg/mL 187 - 883
Method : CMIA
Interpretation:
Low Values are a sign of a vitamin B12 deficiency. People with this deficiency are likely to have or develop symptoms.
Causes of vitamin B12 deficiency include:Not enough vitamin B12 in diet (rare except with a strict vegetarian diet), Diseases that cause
malabsorption (for example, celiac disease and Crohn's disease), Lack of intrinsic factor, Above normal heat production (for example, with
hyperthyroidism), Pregnancy. Increased vitamin B12 levels are uncommon. Usually excess vitamin B12 is removed in the urine. Conditions that can
increase B12 levels include: Liver disease (such as cirrhosis or hepatitis), Myeloproliferative disorders (for example, polycythemia vera and chronic
myelocytic leukemia).
Vitamin B12: Low Levels can cause malabsorption, Lack of intrinsic factor, Above normal heat production (for example, with hyperthyroidism),
Pregnancy.High Level Liver disease, Myeloproliferative disorders (for example, polycythemia vera and chronic myelocytic leukemia).
1. Out of 140 healthy indian population, 91% of Vitamin B 12 concentrations was at lower level: 59.00 pg/ml and upper level: 700.00 pg/ml
"Patients on Biotin supplement may have interference in some immunoassays. Ref: Arch Pathol Lab Med—Vol 141, November 2017. With
individuals taking high dose Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is recommended."
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 11 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Serum Report Date : Mar 24, 2024, 04:06 PM
Barcode No : ZC091787 Report Status : Final Report
BIOCHEMISTRY REPORT
Annual Health Checkup- Advance with Free HsCRP
Vitamin D 25 Hydroxy
Vitamin D 25 - Hydroxy 9.8 ng/mL Deficiency : <30 ng/mL
Method : CMIA
Interpretation:
25-Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with Osteoporosis /
Secondary Hyperparathyroidism while severe deficiency causes Rickets in children and Osteomalacia in adults. Prevalence of Vitamin D
deficiency is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D deficiency and Hypervitaminosis D. It is
also used for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring Vitamin D replacement therapy.
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 12 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Serum Report Date : Mar 24, 2024, 04:06 PM
Barcode No : ZC091787 Report Status : Final Report
BIOCHEMISTRY REPORT
Annual Health Checkup- Advance with Free HsCRP
Thyroid Profile Total
Triiodothyronine (T3) 106.2 ng/dL 70 - 204
Method : CMIA
TotalnThyroxine (T4) 6.42 µg/dL 5.0- 12.5
Method : CMIA
Thyroid Stimulating Hormone (Ultrasensitive) 3.16 mIU/L 0.54 - 5.30
Method : CMIA
Interpretation:
Pregnancy Reference ranges TSH
1 st Trimester 0.1 - 2.5
2 ed Trimester 0.2 - 3.0
3 rd Trimester 0.3 - 3.0
Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH directly
affects thyroid function, malfunction of the pituitary or the hypo - thalamus influences the thyroid gland activity. Disease in any portion of the
thyroid-pitutary-hypothala- mus system may influence the levels of T3 and T4 in the blood. In primary hypothyroidism, TSH levels are
significantly elevated, while in secondary and tertiary hypothyroidism, TSH levels may be low. In addition, in the Euthyroid Sick Syndrome,
multiple alterations in serum thyroid function test findings have been recognized in patients with a wide variety of non-thyroidal illnesses (NTI)
without evidence of preexisting thyroid or hypothalami c-pitutary diseases. Thyroid Binding Globulin (TBG) concentrations remain relatively
constant in healthy individuals. However, pregnancy, excess estrogen's, androgen's, antibiotic steroids and glucocorticoids are known to alter
TBG levels and may cause false thyroid values for Total T3 and T4 tests.
TSH T4 T3 INTERPRETATION
High Normal Normal Mild (subclinical) hypothyroidism
Low or
High Low Hypothyroidism
normal
Low Normal Normal Mild (subclinical) hyperthyroidism
High or High or
Low Hyperthyroidism
normal normal
Low or Low or
Low Nonthyroidal illness; pituitary (secondary) hypothyroidism
normal normal
Thyroid hormone resistance syndrome (a mutation in the thyroid hormone receptor decreases thyroid
Normal High High
hormone function)
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 13 of 14
Patient Name : Mr Ashok Kumar Asthana
DOB/Age/Gender : 43 Y/Male Bill Date : Mar 23, 2024, 07:26 PM
Patient ID / UHID : 7703374/RCL6868767 Sample Collected : Mar 24, 2024, 06:55 AM
Referred By : Dr. Sample Received : Mar 24, 2024, 01:28 PM
Sample Type : Spot Urine Report Date : Mar 24, 2024, 02:40 PM
Barcode No : YA436156 Report Status : Final Report
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.
Page 14 of 14
Terms and Conditions of Reporting
1. The presented findings in the Reports are intended solely for informational and interpretational purposes by the
referring physician or other qualified medical professionals possessing a comprehensive understanding of
reporting units, reference ranges, and technological limitations. The laboratory shall not be held liable for any
interpretation or misinterpretation of the results, nor for any consequential or incidental damages arising from
such interpretation.
2. It is to be presumed that the tests performed pertain to the specimen/sample attributed to the Customer's name
or identification. It is presumed that the verification particulars have been cleared out by the customer or his/her
representation at the point of generation of said specimen / sample. It is hereby clarified that the reports
furnished are restricted solely to the given specimen only.
3. It is to be noted that variations in results may occur between different laboratories and over time, even for the
same parameter for the same Customer. The assays are performed and conducted in accordance with standard
procedures, and the reported outcomes are contingent on the specific individual assay methods and equipment(s)
used, as well as the quality of the received specimen.
4. This report shall not be deemed valid or admissible for any medico-legal purposes.
5. The Customers assume full responsibility for apprising the Company of any factors that may impact the test
finding. These factors, among others, includes dietary intake, alcohol, or medication / drug(s) consumption, or
fasting. This list of factors is only representative and not exhaustive.
Name Patient ID Gender Age
fa lse
Health Advisory
Normal (N) Low (L) Borderline (BL) High (H)
Vitamins Profile
Vitamins are considered essential nutrients because they perform hundreds of roles in your body. They help
maintain bones, heal wounds, and strengthen your immune system. They also convert food into energy, and repair
cellular damage
About Diabetes
This panel is used to check how much glucose/sugar there is in your blood. Too much blood glucose might
indicate diabetes.
NORMAL HIGH
One of the ways to control and reduce your HbA1c level - is to change your diet. Generally, foods that are high in carbs increase
your blood sugar significantly. Also, foods that are high in fiber keep your glucose level in check.
Additionally, keeping your portion sizes small could prevent sharp rises in your blood sugar.
Liver Profile
One of the main functions of your liver is to make proteins that are secreted in your blood. It also makes enzymes
which convert food into energy, and processes old muscles and cells. When your liver is damaged, enzymes leak
into your blood and appear in the blood test
NORMAL HIGH
< 40 > 40
You: 60
Kidney Profile
This panel is used to check healthy functioning of your kidneys. Kidneys filter blood in your body to remove waste
products - these waste products are produced when breakdown of proteins (present in food, muscles and other
cells) occurs in the body to generate energy
Lipid Profile
This panel measures the amount of lipoprotein - a type of fat required to produce energy in your body. Too much fat
restricts oxygen ow to your heart, which may lead to heart disease.
LOW NORMAL
< 55 > 55
You: 44.4